Theravance Biopharma
TBPH
TBPH
98 hedge funds and large institutions have $793M invested in Theravance Biopharma in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
28% less capital invested
Capital invested by funds: $1.1B → $793M (-$306M)
87% less call options, than puts
Call options by funds: $2.26M | Put options by funds: $17.3M
Holders
98
Holding in Top 10
1
Calls
$2.26M
Puts
$17.3M
Top Buyers
| 1 | +$7.54M | |
| 2 | +$4.21M | |
| 3 | +$3.61M | |
| 4 |
JG
Jefferies Group
New York
|
+$3.52M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$2.54M |
Top Sellers
| 1 | -$19.9M | |
| 2 | -$2.1M | |
| 3 | -$1.88M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.71M |
| 5 |
OWIM
Old West Investment Management
Los Angeles,
California
|
-$1.42M |